Md. Norris et al., INVOLVEMENT OF MDR1 P-GLYCOPROTEIN IN MULTIFACTORIAL RESISTANCE TO METHOTREXATE, International journal of cancer, 65(5), 1996, pp. 613-619
Cellular resistance to methotrexate (MTX) is believed to be unaffected
by expression of MDRI P-glycoprotein (Pgp), a pleiotropic efflux pump
acting on different hydrophobic compounds that enter cells by passive
diffusion. A series of human leukemic CCRF-CEM sublines, isolated by
multi-step selection for very high resistance to MTX, exhibit multiple
mechanisms of MTX resistance, including decreased carrier-mediated up
take of MTX and DHFR gene amplification. These sublines show cross-res
istance to drugs of the multi-drug resistance (MDR) family, which is c
orrelated with relative resistance to MTX. The MTX-selected sublines s
how increased expression and function of the MDRI gene, based on the m
easurement of MDRI mRNA, Pgp and rhodamine 123 accumulation. Sequence
analysis of the MDRI cDNA from MTX-selected CCRF-CEM cells revealed no
mutations in the protein coding region. MTX resistance in these cell
lines is partially reversible by a Pgp-specific monoclonal antibody (M
Ab) UIC2 and a monovalent Fab fragment of UIC2. Our results indicate t
hat Pgp can contribute to multifactorial resistance to MTX. (C) 1996 W
iley-Liss, Inc.